| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.003 |